SpeechPathology.com Phone: 800-242-5183


Jobs available nationwide for the 2024-25 school year - Apply Now

Using the MoCA in a Home Healthcare Setting

Kim McCullough, Ph.D., CCC-SLP

March 5, 2013

Share:

Question

I work in a home healthcare setting.  Would the Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) be a good tool to use at evaluation and then later at discharge to get improvement measures?

Answer

The MoCA would be a good screening measurement, but I do not think that the MoCA is the place that you should stop with your evaluation.  The MoCA only takes about 10 minutes to administer.  What I think is going to be important is that in the assessment procedures, we know exactly where those impairment areas are and whether it is a just a single domain or multiple domains.  That is going to direct your treatment.

Kim McCullough, Ph.D., CCC-SLP is an Associate Professor at the University of Central Arkansas (UCA). She has 17 years experience as a clinician, teacher, and researcher in the area of adult neurogenic communication disorders. 


kim mccullough

Kim McCullough, Ph.D., CCC-SLP

Kim McCullough, Ph.D., CCC-SLP is an Associate Professor in the Department of Communication Sciences and Disorders at the University of Central Arkansas. She has 17 years experience as a clinician, teacher, and researcher. She teaches courses on aphasia, cognitive-communication disorders, and the neuroscience of communication. Her current research interests include developing clinically efficient assessment and treatment protocols for individuals with cognitive impairments.  


Related Courses

20Q: Mild Cognitive Impairment - The SLP’s Role in Service Delivery
Presented by Kim McCullough, PhD, CCC-SLP, Anne Hunter Cox
Text

Presenters

Kim McCullough, PhD, CCC-SLPAnne Hunter Cox
Course: #10527Level: Intermediate1 Hour
  'It was very informative and well written'   Read Reviews
Increasingly, SLPs are serving individuals with Mild Cognitive Impairment (MCI). MCI, cognitive reserve, and modifiable risk factors that can reduce the risk of dementia are defined and described in this course. An overview of cognitive/communicative deficits associated with MCI, as well as assessment and management considerations, is also provided.

Textbook: Cognitive Communication Disorders of MCI and Dementia - Definition, Assessment, and Clinical Management
Presented by Kim McCullough, PhD, CCC-SLP, Kathryn A. Bayles, PhD, ASHA Fellow, Cheryl Tomoeda, MS, CCC-SLP
Text

Presenters

Kim McCullough, PhD, CCC-SLPKathryn A. Bayles, PhD, ASHA FellowCheryl Tomoeda, MS, CCC-SLP
Course: #10911Level: Intermediate15.5 Hours
  'Great compilation of information! Thank you so much!'   Read Reviews
Based on the textbook Cognitive Communication Disorders of MCI and Dementia: Definition, Assessment, and Clinical Management, this course provides the knowledge to diagnose and treat individuals with cognitive-communicative disorders associated with aging, mild cognitive impairment (MCI), and dementia-producing diseases, our fastest growing clinical population.

Treatment of Mild Cognitive Impairment
Presented by Kim McCullough, PhD, CCC-SLP
Video

Presenter

Kim McCullough, PhD, CCC-SLP
Course: #8633Level: Intermediate1 Hour
  'confirmation of personal research'   Read Reviews
This course will focus on the treatment of MCI using current best practices. Intervention structure and content, as well as examples of strategies and activities for clinical implementation will be reviewed.

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video

Presenters

Mary Beth Mason, PhD, CCC-SLPRobert W. Serianni, MS, CCC-SLP, FNAP
Course: #9473Level: Intermediate1 Hour
  'Material was presented well and very organized'   Read Reviews
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'Good factual review of neurodegenerative disease and some therapy solutions'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.